SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-17-008384
Filing Date
2017-11-07
Accepted
2017-11-07 16:10:07
Documents
68
Period of Report
2017-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q vvus-20170930x10q.htm 10-Q 1687983
2 EX-31.1 vvus-20170930ex3114e4918.htm EX-31.1 18431
3 EX-31.2 vvus-20170930ex3129c83c6.htm EX-31.2 19778
4 EX-32 vvus-20170930xex32.htm EX-32 14833
  Complete submission text file 0001558370-17-008384.txt   5624702

Data Files

Seq Description Document Type Size
5 EX-101.INS vvus-20170930.xml EX-101.INS 1133526
6 EX-101.SCH vvus-20170930.xsd EX-101.SCH 39484
7 EX-101.CAL vvus-20170930_cal.xml EX-101.CAL 48800
8 EX-101.DEF vvus-20170930_def.xml EX-101.DEF 111844
9 EX-101.LAB vvus-20170930_lab.xml EX-101.LAB 333979
10 EX-101.PRE vvus-20170930_pre.xml EX-101.PRE 249706
Mailing Address 900 E. HAMILTON AVENUE SUITE 550 CAMPBELL CA 95008
Business Address 900 E. HAMILTON AVENUE SUITE 550 CAMPBELL CA 95008 6509345200
VIVUS INC (Filer) CIK: 0000881524 (see all company filings)

IRS No.: 943136179 | State of Incorp.: CA | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-33389 | Film No.: 171183469
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1